Olympic 800-meter finalist Peter Bol on Tuesday said his provisional doping suspension has been lifted after the A and B samples didn't match.
Usually testing of the B sample confirms the original adverse finding in doping cases.
I was just informed that my B sample did not match my A sample, Bol posted on Twitter.
My provisional suspension has been lifted by Sport Integrity Australia.
Sport Integrity Australia later confirmed testing of the B sample by a World Anti-Doping Agency-accredited laboratory showed an atypical finding, but that in itself is not the same as a negative test result.
The investigation into the matter remains ongoing. Sport Integrity Australia will, as part of its investigation, proceed to consider whether any anti-doping rule violations have been committed, the government-backed agency said in a statement.
It is not possible to provide a timeframe at this point.
Bol repeated Tuesday that he's never taken banned performance-enhancing substances and he described the last month as a nightmare.
Athletics Australia announced last month that Bol had failed an out-of-competition test on Oct. 11. The 28-year-old runner's A sample tested positive to the banned drug erythropoietin, known as EPO.
The relief I am feeling is hard to describe. Bol said after the B sample results returned.
The last month has been nothing less than a nightmare. I wish that the results of my A sample had not been leaked, but there is nothing I can do about that.
To say it one more time: I am innocent and have not taken this substance as I was accused."
Bol placed fourth in the 800-meter final at the Tokyo Olympics and was a silver medalist at the 2022 Commonwealth Games.
Richard Ings, the former head of Australia's anti-doping agency, described the differing results from A and B samples as exceedingly rare.
Questions need asking of the lab and how it processed and assessed the A sample," Ings posted on Twitter.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Quarterly Starter
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Access to Exclusive Premium Stories
Over 30 subscriber-only stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app